- Home
- APRE vs IDAI Comparison
APRE vs IDAI Comparison
Compare APRE & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- IDAI
- Stock Information
- Founded
- APRE 2006
- IDAI 2016
- Country
- APRE United States
- IDAI United States
- Employees
- APRE N/A
- IDAI N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- IDAI Computer Software: Prepackaged Software
- Sector
- APRE Health Care
- IDAI Technology
- Exchange
- APRE Nasdaq
- IDAI Nasdaq
- Market Cap
- APRE 8.3M
- IDAI 7.7M
- IPO Year
- APRE 2019
- IDAI N/A
- Fundamental
- Price
- APRE $1.40
- IDAI $4.16
- Analyst Decision
- APRE Strong Buy
- IDAI Strong Buy
- Analyst Count
- APRE 1
- IDAI 1
- Target Price
- APRE $20.00
- IDAI $12.00
- AVG Volume (30 Days)
- APRE 141.8K
- IDAI 246.4K
- Earning Date
- APRE 11-07-2025
- IDAI 11-07-2025
- Dividend Yield
- APRE N/A
- IDAI N/A
- EPS Growth
- APRE N/A
- IDAI N/A
- EPS
- APRE N/A
- IDAI N/A
- Revenue
- APRE $841,012.00
- IDAI $3,366,415.00
- Revenue This Year
- APRE N/A
- IDAI $25.13
- Revenue Next Year
- APRE N/A
- IDAI $164.45
- P/E Ratio
- APRE N/A
- IDAI N/A
- Revenue Growth
- APRE N/A
- IDAI N/A
- 52 Week Low
- APRE $1.31
- IDAI $1.43
- 52 Week High
- APRE $5.00
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- APRE 42.40
- IDAI 58.29
- Support Level
- APRE $1.31
- IDAI $4.13
- Resistance Level
- APRE $1.46
- IDAI $4.58
- Average True Range (ATR)
- APRE 0.09
- IDAI 0.41
- MACD
- APRE -0.01
- IDAI -0.00
- Stochastic Oscillator
- APRE 22.11
- IDAI 51.73
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.